B cells, MKI67+ T cells and dysfunctional T cells, interact with tumor-associated macrophages (TAMs), which are enriched by preoperative chemotherapy, through HLA-F-LILRB2 and HLA-DPB1-NRG1 pathways in the cell niche of primary tumors. The gene discussed is LILRB2; the disease is neoplasm.